91 related articles for article (PubMed ID: 27282574)
1. Flow-cytometry-based evaluation of peripheral blood lymphocytes in prognostication of newly diagnosed DLBCL patients.
Rusak M; Bołkun Ł; Chociej-Stypułkowska J; Pawlus J; Kłoczko J; Dąbrowska M
Blood Cells Mol Dis; 2016 Jul; 59():92-6. PubMed ID: 27282574
[TBL] [Abstract][Full Text] [Related]
2. Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma.
Głowala-Kosińska M; Chwieduk A; Nieckula J; Saduś-Wojciechowska M; Grosicki S; Rusin A; Nowara E; Giebel S
Eur J Haematol; 2013 Aug; 91(2):122-8. PubMed ID: 23679234
[TBL] [Abstract][Full Text] [Related]
3. High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma.
Chang C; Wu SY; Kang YW; Lin KP; Chen TY; Medeiros LJ; Chang KC
Am J Clin Pathol; 2015 Dec; 144(6):935-44. PubMed ID: 26573001
[TBL] [Abstract][Full Text] [Related]
4. [Flow fluorimetry in differential diagnosis of diffuse large B-cell lymphoma].
Vorob'ev IA; Gorgidze LA; Gretsov EM; Korneva EP; Kharazishvili DV; Khudoleeva OA; Churakova ZhV
Ter Arkh; 2006; 78(7):46-51. PubMed ID: 16944750
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Itabashi M; Ishibashi D; Yamamoto E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Hattori Y; Motohashi K; Takasaki H; Ohshima R; Hashimoto C; Yamazaki E; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
Eur J Haematol; 2014 Mar; 92(3):204-10. PubMed ID: 24283206
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in peripheral blood lymphocyte subset counts and functions in patients with diffuse large B cell lymphoma during chemotherapy.
Hou H; Luo Y; Tang G; Zhang B; Ouyang R; Wang T; Huang M; Wu S; Li D; Wang F
Cancer Cell Int; 2021 May; 21(1):282. PubMed ID: 34044841
[TBL] [Abstract][Full Text] [Related]
7. Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape.
Su X; Sun T; Li M; Xia Y; Li M; Wang D; Lu F; Ye J; Ji C
J Transl Med; 2022 Aug; 20(1):378. PubMed ID: 35986288
[TBL] [Abstract][Full Text] [Related]
8. The lower peripheral blood lymphocyte/monocyte ratio assessed during routine follow-up after standard first-line chemotherapy is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.
Yan-Li L; Kang-Sheng G; Yue-Yin P; Yang J; Zhi-Min Z
Leuk Res; 2014 Mar; 38(3):323-8. PubMed ID: 24439567
[TBL] [Abstract][Full Text] [Related]
9. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.
He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C
Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma.
Yu T; Xu-Monette ZY; Lagoo A; Shuai W; Wang B; Neff J; Carrillo LF; Carlsen ED; Pina-Oviedo S; Young KH
Front Immunol; 2024; 15():1335689. PubMed ID: 38348048
[TBL] [Abstract][Full Text] [Related]
11. Correlation between circulating blood and microenvironment T lymphocytes in diffuse large B-cell lymphomas.
Laddaga FE; Ingravallo G; Mestice A; Tamma R; Perrone T; Maiorano E; Ribatti D; Specchia G; Gaudio F
J Clin Pathol; 2022 Jul; 75(7):493-497. PubMed ID: 34011621
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].
Zhang HH; Guo F; Fei R; Ma H; Cong X; Wei L; Chen HS
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):511-5. PubMed ID: 18649763
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of PD-1 and TIM-3 on CD3+ T cells from diffuse large B-cell lymphoma.
Zhang L; Du H; Xiao TW; Liu JZ; Liu GZ; Wang JX; Li GY; Wang LX
Biomed Pharmacother; 2015 Oct; 75():83-7. PubMed ID: 26463635
[TBL] [Abstract][Full Text] [Related]
14. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of de novo CD25(+) diffuse large B-cell lymphoma.
Fujiwara S; Muroi K; Hirata Y; Sato K; Matsuyama T; Ohmine K; Suzuki T; Ozaki K; Mori M; Nagai T; Tanaka A; Ozawa K
Hematology; 2013 Jan; 18(1):14-9. PubMed ID: 22981118
[TBL] [Abstract][Full Text] [Related]
16. Circulating CXCR5+CD4+ T cells assist in the survival and growth of primary diffuse large B cell lymphoma cells through interleukin 10 pathway.
Cha Z; Qian G; Zang Y; Gu H; Huang Y; Zhu L; Li J; Liu Y; Tu X; Song H; Qian B
Exp Cell Res; 2017 Jan; 350(1):154-160. PubMed ID: 27888017
[TBL] [Abstract][Full Text] [Related]
17. The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.
Jelicic J; Balint MT; Jovanovic MP; Boricic N; Micev M; Stojsic J; Antic D; Andjelic B; Bila J; Balint B; Pavlovic S; Mihaljevic B
Pathol Oncol Res; 2016 Jul; 22(3):567-77. PubMed ID: 26750138
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prognostic impact of absolute lymphocyte count, absolute monocyte count, absolute lymphocyte count/absolute monocyte count prognostic score and ratio in patients with diffuse large B cell lymphoma.
Markovic O; Popovic L; Marisavljevic D; Jovanovic D; Filipovic B; Stanisavljevic D; Matovina-Brko G; Hajder J; Matkovic T; Živkovic R; Stanisavljevic N; Todorović M; Petrovic D; Mihaljevic B
Eur J Intern Med; 2014 Mar; 25(3):296-302. PubMed ID: 24565533
[TBL] [Abstract][Full Text] [Related]
19. Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure.
Dong X; Gong Y; Zeng H; Hao Y; Wang X; Hou J; Wang J; Li J; Zhu Y; Liu H; Han J; Zhou H; Shen L; Gao T; Zhou T; Yang S; Li S; Chen Y; Meng Q; Li H
Liver Int; 2013 Nov; 33(10):1517-26. PubMed ID: 23869954
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
Panizo C; Rodríguez AJ; Gutiérrez G; Díaz FJ; González-Barca E; de Oña R; Grande C; Sancho JM; García-Álvarez MF; Sánchez-González B; Peñalver FJ; Cannata J; Espeso M; Requena MJ; Gardella S; Durán S; González AP; Alfonso A; Caballero MD;
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):398-403. PubMed ID: 25843416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]